[Skip to Navigation]
Comment & Response
November 2019

Vitamin B12 Therapy in Older Adults and Misconception of Its Inappropriateness—Reply

Author Affiliations
  • 1Department of Medicine, University of Toronto, Toronto, Ontario, Canada
  • 2Division of Medical Oncology and Hematology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
  • 3Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
  • 4Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
  • 5ICES, Toronto, Ontario, Canada
JAMA Intern Med. 2019;179(11):1606-1607. doi:10.1001/jamainternmed.2019.4902

In Reply We thank Arendt and colleagues and Stall and colleagues for their letters on our study.1 We agree that diagnosing vitamin B12 deficiency can be challenging in elderly patients. To mitigate this, we used a threshold of 221 pmol/L, the least restrictive value for B12 deficiency according to the National Health and Nutrition Examination Survey.1,2 It is also in keeping with Canadian practice guidelines on B12 deficiency, which suggest that symptoms of deficiency are rare with a serum B12 221 pmol/L or greater.3 We also believe that using methylmalonic acid and homocysteine levels as surrogates for deficiency does not reflect real-world practice, given their limited availability, cost, and poor sensitivity with increasing age.4

Add or change institution
×